vs
Side-by-side financial comparison of NATURES SUNSHINE PRODUCTS INC (NATR) and WORKIVA INC (WK). Click either name above to swap in a different company.
WORKIVA INC is the larger business by last-quarter revenue ($238.9M vs $123.8M, roughly 1.9× NATURES SUNSHINE PRODUCTS INC). WORKIVA INC runs the higher net margin — 4.9% vs 3.3%, a 1.6% gap on every dollar of revenue. On growth, WORKIVA INC posted the faster year-over-year revenue change (19.5% vs 4.7%). WORKIVA INC produced more free cash flow last quarter ($50.7M vs $7.6M). Over the past eight quarters, WORKIVA INC's revenue compounded faster (16.6% CAGR vs 5.6%).
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
Workiva, Inc. is a global software-as-a-service (SaaS) company. It provides a cloud-based connected and reporting compliance platform that enables the use of connected data and automation of reporting across finance, accounting, risk, and compliance.
NATR vs WK — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $123.8M | $238.9M |
| Net Profit | $4.1M | $11.8M |
| Gross Margin | 72.5% | 80.7% |
| Operating Margin | 4.3% | 3.3% |
| Net Margin | 3.3% | 4.9% |
| Revenue YoY | 4.7% | 19.5% |
| Net Profit YoY | 1379.4% | 234.0% |
| EPS (diluted) | $0.23 | $0.21 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $123.8M | $238.9M | ||
| Q3 25 | $128.3M | $224.2M | ||
| Q2 25 | $114.8M | $215.2M | ||
| Q1 25 | $113.2M | $206.3M | ||
| Q4 24 | $118.2M | $199.9M | ||
| Q3 24 | $114.6M | $185.6M | ||
| Q2 24 | $110.6M | $177.5M | ||
| Q1 24 | $111.0M | $175.7M |
| Q4 25 | $4.1M | $11.8M | ||
| Q3 25 | $5.3M | $2.8M | ||
| Q2 25 | $5.3M | $-19.4M | ||
| Q1 25 | $4.7M | $-21.4M | ||
| Q4 24 | $-321.0K | $-8.8M | ||
| Q3 24 | $4.3M | $-17.0M | ||
| Q2 24 | $1.3M | $-17.5M | ||
| Q1 24 | $2.3M | $-11.7M |
| Q4 25 | 72.5% | 80.7% | ||
| Q3 25 | 73.3% | 79.3% | ||
| Q2 25 | 71.7% | 77.0% | ||
| Q1 25 | 72.1% | 76.6% | ||
| Q4 24 | 72.0% | 77.1% | ||
| Q3 24 | 71.3% | 76.5% | ||
| Q2 24 | 71.4% | 76.8% | ||
| Q1 24 | 71.2% | 76.4% |
| Q4 25 | 4.3% | 3.3% | ||
| Q3 25 | 7.0% | -1.5% | ||
| Q2 25 | 3.7% | -10.3% | ||
| Q1 25 | 5.4% | -12.0% | ||
| Q4 24 | 3.8% | -6.7% | ||
| Q3 24 | 4.6% | -11.7% | ||
| Q2 24 | 5.1% | -13.0% | ||
| Q1 24 | 4.2% | -10.4% |
| Q4 25 | 3.3% | 4.9% | ||
| Q3 25 | 4.2% | 1.2% | ||
| Q2 25 | 4.6% | -9.0% | ||
| Q1 25 | 4.2% | -10.4% | ||
| Q4 24 | -0.3% | -4.4% | ||
| Q3 24 | 3.8% | -9.2% | ||
| Q2 24 | 1.2% | -9.9% | ||
| Q1 24 | 2.1% | -6.7% |
| Q4 25 | $0.23 | $0.21 | ||
| Q3 25 | $0.30 | $0.05 | ||
| Q2 25 | $0.28 | $-0.35 | ||
| Q1 25 | $0.25 | $-0.38 | ||
| Q4 24 | $-0.02 | $-0.15 | ||
| Q3 24 | $0.23 | $-0.31 | ||
| Q2 24 | $0.07 | $-0.32 | ||
| Q1 24 | $0.12 | $-0.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $93.9M | $338.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $161.6M | $-5.4M |
| Total Assets | $261.1M | $1.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $93.9M | $338.8M | ||
| Q3 25 | $95.6M | $315.9M | ||
| Q2 25 | $81.3M | $284.3M | ||
| Q1 25 | $86.5M | $242.0M | ||
| Q4 24 | $84.7M | $301.8M | ||
| Q3 24 | $78.7M | $248.2M | ||
| Q2 24 | $68.7M | $267.9M | ||
| Q1 24 | $77.8M | $296.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $2.1M | — |
| Q4 25 | $161.6M | $-5.4M | ||
| Q3 25 | $166.7M | $-36.9M | ||
| Q2 25 | $163.7M | $-66.5M | ||
| Q1 25 | $167.1M | $-75.7M | ||
| Q4 24 | $161.0M | $-41.7M | ||
| Q3 24 | $162.6M | $-50.8M | ||
| Q2 24 | $156.4M | $-77.7M | ||
| Q1 24 | $159.7M | $-83.2M |
| Q4 25 | $261.1M | $1.5B | ||
| Q3 25 | $264.8M | $1.4B | ||
| Q2 25 | $254.9M | $1.3B | ||
| Q1 25 | $252.7M | $1.3B | ||
| Q4 24 | $240.9M | $1.4B | ||
| Q3 24 | $245.3M | $1.3B | ||
| Q2 24 | $235.8M | $1.2B | ||
| Q1 24 | $247.3M | $1.2B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.01× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $9.9M | $51.0M |
| Free Cash FlowOCF − Capex | $7.6M | $50.7M |
| FCF MarginFCF / Revenue | 6.1% | 21.2% |
| Capex IntensityCapex / Revenue | 1.9% | 0.1% |
| Cash ConversionOCF / Net Profit | 2.41× | 4.31× |
| TTM Free Cash FlowTrailing 4 quarters | $28.8M | $138.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $9.9M | $51.0M | ||
| Q3 25 | $18.5M | $46.2M | ||
| Q2 25 | $4.3M | $50.3M | ||
| Q1 25 | $2.6M | $-7.4M | ||
| Q4 24 | $12.2M | $44.0M | ||
| Q3 24 | $9.6M | $18.9M | ||
| Q2 24 | $1.3M | $-14.0K | ||
| Q1 24 | $2.2M | $24.8M |
| Q4 25 | $7.6M | $50.7M | ||
| Q3 25 | $16.8M | $46.1M | ||
| Q2 25 | $3.0M | $49.3M | ||
| Q1 25 | $1.5M | $-8.1M | ||
| Q4 24 | $10.0M | $43.2M | ||
| Q3 24 | $7.9M | $18.7M | ||
| Q2 24 | $-2.0M | $-122.0K | ||
| Q1 24 | $-1.5M | $24.6M |
| Q4 25 | 6.1% | 21.2% | ||
| Q3 25 | 13.1% | 20.5% | ||
| Q2 25 | 2.6% | 22.9% | ||
| Q1 25 | 1.3% | -3.9% | ||
| Q4 24 | 8.5% | 21.6% | ||
| Q3 24 | 6.9% | 10.1% | ||
| Q2 24 | -1.9% | -0.1% | ||
| Q1 24 | -1.4% | 14.0% |
| Q4 25 | 1.9% | 0.1% | ||
| Q3 25 | 1.3% | 0.0% | ||
| Q2 25 | 1.2% | 0.5% | ||
| Q1 25 | 1.0% | 0.4% | ||
| Q4 24 | 1.9% | 0.4% | ||
| Q3 24 | 1.5% | 0.1% | ||
| Q2 24 | 3.0% | 0.1% | ||
| Q1 24 | 3.3% | 0.1% |
| Q4 25 | 2.41× | 4.31× | ||
| Q3 25 | 3.46× | 16.57× | ||
| Q2 25 | 0.81× | — | ||
| Q1 25 | 0.55× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.21× | — | ||
| Q2 24 | 0.97× | — | ||
| Q1 24 | 0.94× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
WK
| License And Service | $219.3M | 92% |
| XBRL Professional Services | $16.4M | 7% |
| Other Services | $3.2M | 1% |
